Clinical Trial 23347

• Overview

  Study Title:

  A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer (HERO*)

• Treatments

  Therapies:

  Chemotherapy (NOS); Hormonal Therapy; Immunotherapy; Radiotherapy

  Medications:

  Anastrozole (); Arimadex (Anastrozole); Aromasin (Exemestane); Exemestane (); Femara (Letrozole); Herceptin (Trastuzumab); Letrozole (); Pertuzumab (); Tamoxifen (); Trastuzumab (); rhuMAb HER2 (Trastuzumab)

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.